Taken together, the data suggest that healthy donor PBMCs increase their expression of CCL3, IL8 and IL1β (with little or no increases in CXCL10 and IL2Rα) when they are exposed to lung cancer cells (Figures 4and5). The gene discussed is CCL3; the disease is lung cancer.